Yashoda Super Speciality Hospital partners with HaystackAnalytics, forays into Genomic Testing
Delhi: Yashoda Super Speciality Hospital, Kaushambi, a tertiary care hospital committed to offering affordable healthcare services to all, is proud to announce its groundbreaking collaboration with HaystackAnalytics, to bring state-of-the-art genomics solution right to the comfort of consumers’ homes in Delhi NCR.
The IIT Bombay-based health-tech company, supported by the Department of Science & Technology, Govt of India, healthcare veterans like Dr Velumani, and private players such as GE Healthcare and Intel, will be deploying the first-of-its-kind test at Yashoda Super Speciality Hospital, Kaushambi, bringing about a considerable shift in the way preventive healthcare services are delivered in the region.
Also Read:First in India: Yashoda Hospitals Hyderabad joins Metaverse platform
By combining Haystack's cutting-edge genomic testing expertise with Yashoda Super Speciality Hospital, Kaushambi's renowned healthcare facilities, this strategic partnership aims to provide the city with unparalleled access to advanced diagnostic capabilities. With the advent of advanced technology and the growing concerns for preventive healthcare, HaystackAnalytics has empowered the medical practitioners at Yashoda Super Speciality Hospital, Kaushambi to extend its reach beyond the confines of the traditional hospital settings and deliver advanced medical care, diagnostics, and consultation services directly to consumers' homes, revolutionizing the healthcare landscape.
Dr P N Arora, CMD, from Yashoda Super Speciality Hospital, Kaushambi said, “We are excited to partner with HaystackAnalytics to bring the preventive genomics directly to our patients. This collaboration aligns with our commitment to deliver exceptional healthcare services and further reinforces our mission to make quality medical care accessible to all.”
Dr Anirvan Chatterjee, CEO HaystackAnalytics said, “This partnership is a testament to our commitment to harness the potential of cutting-edge technologies for the betterment of patient care, and we are excited to front end this groundbreaking journey into the world of genomics. These collaborations allow HaystackAnalytics to showcase the growing acceptance and preference of genomics for preventive and primary healthcare. Post the success of launching the first-ever genomics-based comprehensive preventive health solution test in Mumbai in collaboration with Wockhardt Hospital and Godrej Memorial Hospital, now we are paving our way into the capital through diverse collaborations, to Yashoda Hospital, the pioneers in healthcare services. Together, we can unlock the immense potential of genomics for the benefit of patients.”
Smart Gene Plan is a completely automated AI-based bioinformatics platform used to create consumer-focused wellness products. This ground-breaking programme aims to give people a personalised, circuit-view of preventative healthcare, including early identification of potential future health issues using pathological and genetic studies. It is the first-of-its-kind genome test for preventative healthcare that examines the entire exome, encompassing more than 7000 genes, close to 9000 mutations, and significant blood parameters to determine the underlying disease predispositions.
Dr Upasana Arora, CEO & Director from Yashoda Super Speciality Hospital, Kaushambi said, “In India, the need for preventive healthcare has become more critical than ever before. By prioritizing preventive measures, we can proactively address health concerns, promote wellness, and create a healthier nation. And by harnessing the power of genomics, we will be able to achieve the knowledge of understanding valuable insights into an individual’s genetic predispositions, enabling personalized preventive strategies.”
Addressing the gathering, Dr Aparna Bhanushali, Head of Growth and Scientific Support, HaystackAnalytics stated, “According to a recent report by the International Diabetes Federation, India is currently home to the most people with diabetes in the world, numbering around 77 million, and the report also indicates that this number is projected to rise to 134 million by 2045. This is an alarming statistic that highlights the urgent need for preventive measures. In addition, India also witnesses a significant number of premature deaths due to cardiovascular disease, which accounts for a quarter of all deaths. This is where the Smart Gene Plan is equipped to provide a comprehensive solution to this crisis, by allowing for early identification of health issues and providing necessary treatment to those in need.”
This collaboration between Yashoda Super Speciality Hospital, Kaushambi and HaystackAnalytics signifies a significant step forward in the integration of genomics into mainstream healthcare. It highlights the commitment of both organizations to embrace cutting-edge technologies and deliver patient-centric care that is tailored to individual genetic profiles. By incorporating genomic data, healthcare providers will gain a deeper understanding of genetic variations, disease risks, and potential treatment responses, leading to more personalized and effective healthcare interventions.
